Groen, Roos A. http://orcid.org/0000-0002-1861-273X
Jukema, J. Wouter
van Dijkman, Paul R. M.
Bax, Jeroen J.
Lamb, Hildo J.
Antoni, M. Louisa
de Graaf, Michiel A.
Article History
Received: 21 November 2023
Accepted: 16 January 2024
First Online: 13 February 2024
Declarations
:
: J. Wouter Jukema/his department has received research grants from and/or was speaker (with or without lecture fees) on a.o. (CME accredited) meetings sponsored/supported by Abbott, Amarin, Amgen, Athera,, Biotronik, Boston Scientific, Dalcor, Daiichi Sankyo, Edwards Lifesciences, GE Healthcare Johnson and Johnson, Lilly, Medtronic, Merck-Schering-Plough, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi Aventis, the Netherlands Heart Foundation, CardioVascular Research the Netherlands (CVON), the Netherlands Heart Institute and the European Community Framework KP7 Programme. This funding was not applied to the current research. Roos A. Groen, Paul R.M. van Dijkman, Jeroen J. Bax, Hildo J. Lamb, M. Louisa. Antoni and Michiel A. de Graaf declare they have no conflicts of interest for the present manuscript.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.